Terns Pharmaceuticals $65 million common stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Precigen sale of Trans Ova Genetics to URUS
We are advising Precigen on the transaction
Gracell Biotechnologies at-the-market offering
The ADSs are listed on the Nasdaq Global Select Market
Ormat Technologies $375 million convertible senior notes offering
The 2.5% convertible notes are due 2027
Grupo Aval spinoff of BAC Holding International
We advised Grupo Aval on the unregistered spinoff of a 75% equity stake in its indirect subsidiary
Grupo Aval consent solicitation
We advised Grupo Aval on its consent solicitation
Stanley Black & Decker $1 billion senior notes offering
The 2.3% investment-grade notes are due 2025 and the 3% investment-grade notes are due 2032
Perion Network $180 million follow-on offering
We advised Perion on the offering of ordinary shares
GT Gettaxi business combination with Rosecliff Acquisition
We are advising GT Gettaxi on the transaction
Inventiva at-the-market offering
We advised the sales agent on the SEC-registered offering of ADSs